SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
EVERSON LLOYD K

(Last) (First) (Middle)
16825 NORTHCHASE DRIVE
SUITE 1300

(Street)
HOUSTON 77060

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
US ONCOLOGY INC [ USON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2004
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/20/2004 J(1) 17,000 D $15.5 0 D
Common Stock 08/20/2004 J(1) 23,402 D $15.05 0 I Owned by an IRA of the reporting person.
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $7.7 08/20/2004 J(2) 16,000 03/22/2000 03/22/2009 Common Stock 16,000 $0 0 D
Stock Options $4.12 08/20/2004 J(2) 16,666 04/24/2002 10/24/2011 Common Stock 16,666 $0 0 D
Stock Options $4.02 08/20/2004 J(2) 20,000 03/21/2001 03/20/2010 Common Stock 20,000 $0 0 D
Stock Options $8.45 08/20/2004 J(2) 25,000 03/22/2002 03/22/2011 Common Stock 25,000 $0 0 D
Stock Options $7.97 08/20/2004 J(2) 50,000 11/13/2003 11/13/2012 Common Stock 50,000 $0 0 D
Stock Options $14.61 08/20/2004 J(2) 75,000 05/14/1999 05/14/2008 Common Stock 75,000 $0 0 D
Stock Options $6.99 08/20/2004 J(2) 80,000 08/08/2003 08/08/2012 Common Stock 80,000 $0 0 D
Stock Options $10.08 08/20/2004 J(2) 120,000 06/15/2000 06/15/2009 Common Stock 120,000 $0 0 D
Stock Options $15.71 08/20/2004 J(3) 175,000 08/14/1998 08/14/2007 Common Stock 175,000 $0 0 D
Stock Options $7.7 08/20/2004 J(2) 220,092 08/19/2010 08/19/2013 Common Stock 220,092 $0 0 D
Explanation of Responses:
1. Disposed of in the merger of the issuer with Oiler Acquisition Corp. effective Aug. 20, 2004 (the "Merger") pursuant to Merger agreement between issuer, Oiler Acquisition Corp. and US Oncology Holdings, Inc. pursuant to which stockholders of the issuer were paid $15.05 per share.
2. This option was canceled in the Merger of the issuer with Oiler Acquisition Corp. effective Aug. 20, 2004 in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between the exercise price of the option and $15.05.
3. This option was canceled in the Merger of the issuer with Oiler Acquisition Corp. effective Aug. 20, 2004 for no consideration.
Remarks:
B. Scott Aitken, Power of Attorney 08/23/2004
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.